<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="625">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02004236</url>
  </required_header>
  <id_info>
    <org_study_id>Autism and tRNS</org_study_id>
    <nct_id>NCT02004236</nct_id>
  </id_info>
  <brief_title>Transcranial Random Noise Stimulation (tRNS) Over Fronto-temporal Cortex Improves Verbal Fluency and Empathy in Autism Children</brief_title>
  <acronym>tRNS25112013</acronym>
  <official_title>Transcranial Random Noise Noninvasive Brain Stimulation Applied to the Fronto-temporal Cortex Improves Verbal Fluency and Emphaty in Children With Autistic Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spanish Foundation for Neurometrics Development</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spanish Foundation for Neurometrics Development</source>
  <oversight_info>
    <authority>Spain: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, prospective, randomized, double-blind, placebo-controlled and parallel
      assignment study, in which patients with Autism Spectrum Disorder (ASD) are two types of
      intervention by transcranial random noise stimulation (tRNS), to improve verbal fluency and
      empathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional, prospective, randomized, double-blind, placebo-controlled and parallel
      assignment study, in which patients receive three types of intervention tRNS: one group
      received 35 sessions focused on the fronto-temporal cortex, another group received 35
      sessions focused on the temporal fusiform cortex and last placebo group was operated with 35
      sessions tRNS. After brain noninvasive stimulation sessions, a blind analysis of the
      improvement in verbal fluency and empathy in patients with autism spectrum disorder is made.
      For each patient included a follow up period of three months will be established.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Verbal Fluency</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Goal: Improve in verbal fluency in ASD children between 5 and 12 years. We use D-KEFS (Delis-Kaplan Executive Function System Delis Kaplan Sorting Test), Verbal Fluency Subtest - Category Condition.
Description: The verbal fluency Category test evaluates fluent productivity in the verbal domain by asking participants to generate exemplars belonging to the category animals, and subsequently, boys´ names. Participants were given 60 s to do it.
Values: Category scores were based on the average number of items generated in the two categories (animals and boys´names) during 60 s.
Time Frame: Baseline (Before treatment) and 1 day Post-treatment (after completing 3 months of intensive speech therapy during tRNS sessions)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sociability</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Goal: Evaluate emphaty with CARS scale in autism spectrum disorder children between 5 and 12 years after tRNS sessions.
CARS (Childhood Autism Rating Scale) by Shopler &amp; Reichler (1971) in Spanish version EVAI (Escala de Valoración de Autismo Infantil) by Leal-Soto, F.; Aguirre, L.P. y Williams, E.E.
Description: 15 items in the scale that evaluate: Relating to people, Imitative Behavior, Emotional Response, Body Use, Object Use, Adaptation to Change, Visual Response, Listening Response, Perceptive Response, Fear or Anxiety, Verbal Communication, Non-Verbal Communication, Activity level, Level and consistency of Intellective Relations and General Impressions.
Values: The CARS scores range from 15 to 60, with lower scores indicating better outcome. It classifies the child as not autistic (below 30), moderately autistic (30-36.5) or severely autistic (above 36.5)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ratio Theta/Beta Before tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Theta Amplitude in T5 Before tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio Theta/Beta After tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Theta Amplitude in T5 After tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Evaluate QEEG (brainwave changes in frequency bandfs and amplitude) after tRNS intervention in ASD children between 5 and 12 years old</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reaction Time in ECPT Before tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>ERP &amp; Behaviour changes in ASD children after tRNS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Omission Errors Before tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>ERP and behaviour changes in ASD children before tRNS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Commission Errors Before tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>ERP and Behaviour changes in ASD children before tRNS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>P3b Wave Amplitude Before tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>ERP and behaviour Changes in ASD children before tRNS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reaction Time After tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>ERP and behaviour Changes in ASD children after tRNS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ommision Errors After tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>ERP and behaviour Changes in ASD children after tRNS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Commission Errors After tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>ERP and behaviour Changes in ASD children after tRNS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>P3b Wave Amplitude After tRNS</measure>
    <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>ERP and behaviour Changes in ASD children after tRNS</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Autism</condition>
  <condition>ASD</condition>
  <arm_group>
    <arm_group_label>tRNS Fronto-temporal cortex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tRNS over fusiform temporal cortex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tRNS with sham</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group receive 35 sessions with sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tRNS Fronto-temporal cortex</intervention_name>
    <description>This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
    <arm_group_label>tRNS Fronto-temporal cortex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tRNS over fusiform temporal cortex</intervention_name>
    <description>This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
    <arm_group_label>tRNS over fusiform temporal cortex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tRNS with sham</intervention_name>
    <description>the subjects receive 35 session with sham</description>
    <arm_group_label>tRNS with sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 5 and 12 years.

          -  Meet DSM-IV criteria for autism spectrum disorder.

          -  Patients who have been diagnosed at least 2 years before inclusion in the study.

        Exclusion Criteria:

          -  Acute visual or hearing loss.

          -  Traumatic brain injury.

          -  Other neurological disorders: migraine, epilepsy, tuberous sclerosis ...

          -  Trauma at birth.

          -  Mental retardation.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moises Aguilar Domingo, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Spanish Foundation for Neurometrics Development</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Elche Hospital</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <zip>03203</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.dep20.san.gva.es/</url>
    <description>General Elche Hospital</description>
  </link>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 21, 2015</lastchanged_date>
  <firstreceived_date>November 25, 2013</firstreceived_date>
  <firstreceived_results_date>September 16, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tRNS</keyword>
  <keyword>QEEG</keyword>
  <keyword>ERP</keyword>
  <keyword>ASD</keyword>
  <keyword>Autism</keyword>
  <keyword>verbal fluency</keyword>
  <keyword>empathy</keyword>
  <keyword>noninvasive brain stimulation</keyword>
  <keyword>tDCS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>tRNS Over Fronto-temporal Cortex</title>
          <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
        </group>
        <group group_id="P2">
          <title>tRNS Over Fusiform Temporal Cortex</title>
          <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
        </group>
        <group group_id="P3">
          <title>tRNS With Sham</title>
          <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="59">Leave the group because the parents does't find any clinical improvement.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Clinically referred sample of young children between 5 and 12 years old with ASD</population>
      <group_list>
        <group group_id="B1">
          <title>tRNS Fronto-temporal Cortex</title>
          <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
        </group>
        <group group_id="B2">
          <title>tRNS Over Fusiform Temporal Cortex</title>
          <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
        </group>
        <group group_id="B3">
          <title>tRNS With Sham</title>
          <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="75"/>
                <measurement group_id="B2" value="75"/>
                <measurement group_id="B3" value="59"/>
                <measurement group_id="B4" value="209"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="7.5" spread="1.98"/>
                <measurement group_id="B2" value="6.9" spread="2.1"/>
                <measurement group_id="B3" value="7.2" spread="2.3"/>
                <measurement group_id="B4" value="7.2" spread="2.12"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="75"/>
                <measurement group_id="B2" value="75"/>
                <measurement group_id="B3" value="59"/>
                <measurement group_id="B4" value="209"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <sub_title>4-6 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="5.1" spread="0.80"/>
                <measurement group_id="B2" value="4.8" spread="1.17"/>
                <measurement group_id="B3" value="5.3" spread="0.75"/>
                <measurement group_id="B4" value="5.06" spread="0.91"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>7-9 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="7.2" spread="0.9"/>
                <measurement group_id="B2" value="8.4" spread="0.73"/>
                <measurement group_id="B3" value="7.8" spread="1.1"/>
                <measurement group_id="B4" value="7.8" spread="0.91"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>10-12 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="11.2" spread="0.48"/>
                <measurement group_id="B2" value="10.1" spread="0.69"/>
                <measurement group_id="B3" value="10.8" spread="0.88"/>
                <measurement group_id="B4" value="10.7" spread="0.68"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="75"/>
                <measurement group_id="B2" value="75"/>
                <measurement group_id="B3" value="59"/>
                <measurement group_id="B4" value="209"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Spain</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="75"/>
                <measurement group_id="B2" value="75"/>
                <measurement group_id="B3" value="59"/>
                <measurement group_id="B4" value="209"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Verbal Fluency</title>
        <description>Goal: Improve in verbal fluency in ASD children between 5 and 12 years. We use D-KEFS (Delis-Kaplan Executive Function System Delis Kaplan Sorting Test), Verbal Fluency Subtest - Category Condition.
Description: The verbal fluency Category test evaluates fluent productivity in the verbal domain by asking participants to generate exemplars belonging to the category animals, and subsequently, boys´ names. Participants were given 60 s to do it.
Values: Category scores were based on the average number of items generated in the two categories (animals and boys´names) during 60 s.
Time Frame: Baseline (Before treatment) and 1 day Post-treatment (after completing 3 months of intensive speech therapy during tRNS sessions)</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>Time frame: Baseline Before treatment and after completing 3 months of intensive speech therapy during tRNS sessions.</population>
        <group_list>
          <group group_id="O1">
            <title>tRNS Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Verbal Fluency</title>
            <description>Goal: Improve in verbal fluency in ASD children between 5 and 12 years. We use D-KEFS (Delis-Kaplan Executive Function System Delis Kaplan Sorting Test), Verbal Fluency Subtest - Category Condition.
Description: The verbal fluency Category test evaluates fluent productivity in the verbal domain by asking participants to generate exemplars belonging to the category animals, and subsequently, boys´ names. Participants were given 60 s to do it.
Values: Category scores were based on the average number of items generated in the two categories (animals and boys´names) during 60 s.
Time Frame: Baseline (Before treatment) and 1 day Post-treatment (after completing 3 months of intensive speech therapy during tRNS sessions)</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>before tRNS</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="9.3" spread="1.3"/>
                  <measurement group_id="O2" value="10.5" spread="1.6"/>
                  <measurement group_id="O3" value="9.9" spread="1.1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>after tRNS</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="8.3" spread="1.2"/>
                  <measurement group_id="O2" value="10.4" spread="1.1"/>
                  <measurement group_id="O3" value="10" spread="0.9"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sociability</title>
        <description>Goal: Evaluate emphaty with CARS scale in autism spectrum disorder children between 5 and 12 years after tRNS sessions.
CARS (Childhood Autism Rating Scale) by Shopler &amp; Reichler (1971) in Spanish version EVAI (Escala de Valoración de Autismo Infantil) by Leal-Soto, F.; Aguirre, L.P. y Williams, E.E.
Description: 15 items in the scale that evaluate: Relating to people, Imitative Behavior, Emotional Response, Body Use, Object Use, Adaptation to Change, Visual Response, Listening Response, Perceptive Response, Fear or Anxiety, Verbal Communication, Non-Verbal Communication, Activity level, Level and consistency of Intellective Relations and General Impressions.
Values: The CARS scores range from 15 to 60, with lower scores indicating better outcome. It classifies the child as not autistic (below 30), moderately autistic (30-36.5) or severely autistic (above 36.5)</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>Time frame: Baseline Before treatment and after completing 3 months of intensive speech therapy during tRNS sessions.</population>
        <group_list>
          <group group_id="O1">
            <title>tRNS Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Sociability</title>
            <description>Goal: Evaluate emphaty with CARS scale in autism spectrum disorder children between 5 and 12 years after tRNS sessions.
CARS (Childhood Autism Rating Scale) by Shopler &amp; Reichler (1971) in Spanish version EVAI (Escala de Valoración de Autismo Infantil) by Leal-Soto, F.; Aguirre, L.P. y Williams, E.E.
Description: 15 items in the scale that evaluate: Relating to people, Imitative Behavior, Emotional Response, Body Use, Object Use, Adaptation to Change, Visual Response, Listening Response, Perceptive Response, Fear or Anxiety, Verbal Communication, Non-Verbal Communication, Activity level, Level and consistency of Intellective Relations and General Impressions.
Values: The CARS scores range from 15 to 60, with lower scores indicating better outcome. It classifies the child as not autistic (below 30), moderately autistic (30-36.5) or severely autistic (above 36.5)</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>before tRNS</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="30.6" spread="1.9"/>
                  <measurement group_id="O2" value="32.1" spread="2.2"/>
                  <measurement group_id="O3" value="31.8" spread="3.4"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>after tRNS</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="19.4" spread="2.1"/>
                  <measurement group_id="O2" value="20.2" spread="1.8"/>
                  <measurement group_id="O3" value="30.1" spread="2.5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio Theta/Beta Before tRNS</title>
        <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ratio Theta/Beta Before tRNS</title>
            <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
            <units>Ratio theta/beta before tRNS</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="25" spread="0.88"/>
                  <measurement group_id="O2" value="30" spread="1.1"/>
                  <measurement group_id="O3" value="26" spread="0.53"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Theta Amplitude in T5 Before tRNS</title>
        <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Theta Amplitude in T5 Before tRNS</title>
            <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
            <units>MicroVolts</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3.2" spread="0.3"/>
                  <measurement group_id="O2" value="2.7" spread="0.11"/>
                  <measurement group_id="O3" value="3.5" spread="0.5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio Theta/Beta After tRNS</title>
        <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ratio Theta/Beta After tRNS</title>
            <description>The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.</description>
            <units>Ratio theta/beta after tRNS</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="12" spread="1.1"/>
                  <measurement group_id="O2" value="14" spread="0.52"/>
                  <measurement group_id="O3" value="25" spread="0.77"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Theta Amplitude in T5 After tRNS</title>
        <description>Evaluate QEEG (brainwave changes in frequency bandfs and amplitude) after tRNS intervention in ASD children between 5 and 12 years old</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Theta Amplitude in T5 After tRNS</title>
            <description>Evaluate QEEG (brainwave changes in frequency bandfs and amplitude) after tRNS intervention in ASD children between 5 and 12 years old</description>
            <units>MicroVolts</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2.2" spread="0.41"/>
                  <measurement group_id="O2" value="1.5" spread="0.36"/>
                  <measurement group_id="O3" value="3.3" spread="0.84"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reaction Time in ECPT Before tRNS</title>
        <description>ERP &amp; Behaviour changes in ASD children after tRNS</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Reaction Time in ECPT Before tRNS</title>
            <description>ERP &amp; Behaviour changes in ASD children after tRNS</description>
            <units>Milliseconds</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="756" spread="23.5"/>
                  <measurement group_id="O2" value="698" spread="34.2"/>
                  <measurement group_id="O3" value="722" spread="18.9"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Omission Errors Before tRNS</title>
        <description>ERP and behaviour changes in ASD children before tRNS</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Omission Errors Before tRNS</title>
            <description>ERP and behaviour changes in ASD children before tRNS</description>
            <units>number of errors during ECPT task</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85" spread="5.2"/>
                  <measurement group_id="O2" value="91" spread="3.2"/>
                  <measurement group_id="O3" value="88" spread="4.6"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Commission Errors Before tRNS</title>
        <description>ERP and Behaviour changes in ASD children before tRNS</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Commission Errors Before tRNS</title>
            <description>ERP and Behaviour changes in ASD children before tRNS</description>
            <units>number of errors during ECPT task</units>
            <param>Median</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="6" spread="0.2"/>
                  <measurement group_id="O2" value="8" spread="1.1"/>
                  <measurement group_id="O3" value="19" spread="0.9"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>P3b Wave Amplitude Before tRNS</title>
        <description>ERP and behaviour Changes in ASD children before tRNS</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>P3b Wave Amplitude Before tRNS</title>
            <description>ERP and behaviour Changes in ASD children before tRNS</description>
            <units>MicroVolts</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.12"/>
                  <measurement group_id="O2" value="0.7" spread="0.4"/>
                  <measurement group_id="O3" value="0.3" spread="0.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reaction Time After tRNS</title>
        <description>ERP and behaviour Changes in ASD children after tRNS</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Reaction Time After tRNS</title>
            <description>ERP and behaviour Changes in ASD children after tRNS</description>
            <units>Milliseconds</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="690" spread="10.4"/>
                  <measurement group_id="O2" value="556" spread="7.4"/>
                  <measurement group_id="O3" value="714" spread="3.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ommision Errors After tRNS</title>
        <description>ERP and behaviour Changes in ASD children after tRNS</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <posting_date>12/2015</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Commission Errors After tRNS</title>
        <description>ERP and behaviour Changes in ASD children after tRNS</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Commission Errors After tRNS</title>
            <description>ERP and behaviour Changes in ASD children after tRNS</description>
            <units>number of errors during ECPT task</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="6" spread="0.2"/>
                  <measurement group_id="O2" value="8" spread="1.1"/>
                  <measurement group_id="O3" value="19" spread="0.9"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>P3b Wave Amplitude After tRNS</title>
        <description>ERP and behaviour Changes in ASD children after tRNS</description>
        <time_frame>During 3 months of intensive speech therapy during tRNS sessions</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>tRNS Over Fronto-temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
          </group>
          <group group_id="O2">
            <title>tRNS Over Fusiform Temporal Cortex</title>
            <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
          </group>
          <group group_id="O3">
            <title>tRNS With Sham</title>
            <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="75"/>
                  <measurement group_id="O2" value="75"/>
                  <measurement group_id="O3" value="59"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>P3b Wave Amplitude After tRNS</title>
            <description>ERP and behaviour Changes in ASD children after tRNS</description>
            <units>MicroVolts</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="0.25"/>
                  <measurement group_id="O2" value="1.8" spread="0.65"/>
                  <measurement group_id="O3" value="0.4" spread="0.32"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>tRNS Fronto-temporal Cortex</title>
          <description>This group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS Fronto-temporal cortex: This group receive 35 sessions of tRNS over fronto-temporal cortex</description>
        </group>
        <group group_id="E2">
          <title>tRNS Over Fusiform Temporal Cortex</title>
          <description>This group receive 35 sessions of tRNS over fusiform temporal cortex
tRNS over fusiform temporal cortex: This group receive 35 sessions of tRNS over fusiform temporal cortex</description>
        </group>
        <group group_id="E3">
          <title>tRNS With Sham</title>
          <description>This group receive 35 sessions with sham
tRNS with sham: the subjects receive 35 session with sham</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>Dizziness</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <description>The children are disorientated in time and space at least during 1 or 2 hours after tRNS session</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Moises Aguilar president of Brainmech Foundation</name_or_title>
      <organization>BrainMech Foundation</organization>
      <phone>+34 634548720</phone>
      <email>moises@brainmech.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
